Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Leveraging neuroscience education to address stigma related to opioid use disorder (OUD) in the community: A pilot study

View ORCID ProfileEvan J. Kyzar, Melissa Arbuckle, Adam Abba-Aji, Krishna Balachandra, Joseph Cooper, Adriane Dela Cruz, Ellen Edens, Brady Heward, Michael Jibson, Ayana Jordan, Daniel Moreno-De-Luca, Hannah Pazderka, Mohit Singh, Jeremy Weleff, Bernice Yau, Justin Young, David A. Ross National Neuroscience Curriculum Initiative (NNCI)
doi: https://doi.org/10.1101/2023.12.11.23299824
Evan J. Kyzar
1Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Evan J. Kyzar
  • For correspondence: Evan.Kyzar{at}nyspi.columbia.edu
Melissa Arbuckle
1Department of Psychiatry, Columbia University Irving Medical Center, New York State Psychiatric Institute, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Abba-Aji
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krishna Balachandra
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Cooper
3Department of Psychiatry, University of Illinois - Chicago, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adriane Dela Cruz
4Department of Psychiatry, University of Texas – Southwestern Medical Center, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ellen Edens
5Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brady Heward
5Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
6Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, Vermont, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Jibson
7Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayana Jordan
8Department of Psychiatry, New York University School of Medicine, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Moreno-De-Luca
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
9CASA Mental Health, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannah Pazderka
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohit Singh
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Weleff
5Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
10Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernice Yau
4Department of Psychiatry, University of Texas – Southwestern Medical Center, Dallas, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Young
5Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Ross
2Department of Psychiatry, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Opioid use disorder (OUD) and overdose deaths are a public health crisis. One contributing factor is stigma towards people who use opioids. We developed and conducted a public-facing, half-day educational event designed to challenge misperceptions about OUD from a contemporary neuroscience perspective. Participants engaged with three different resources on the neurobiology of addiction; at the end of the event, they rated its effectiveness. We also collected and compared pre- and post-event composite OUD stigma scales. Participants rated our approach and the overall event as highly effective. Additionally, OUD stigma scores were lower immediately following the event, and this decrease was primarily driven by decreased internalized stigma. Here, we demonstrate an effective proof-of-concept that an accessible, public-facing, neuroscience education event may reduce OUD stigma in the community.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The NNCI is funded in part by the Deeda Blair Research Initiative Fund for Disorders of the Brain through support to the Foundation for the National Institutes of Health, with additional funding from the Society of Biological Psychiatry (SOBP) and the American College of Neuropsychopharmacology (ACNP). EJK is supported by a training grant through the National Institute of Mental Health (R25 MH086466) and the Leon Levy Fellowship in Neuroscience. MA is supported by the above-named National Institute of Mental Health grant (R25 MH086466). AA-A is supported by grants from the New Frontiers in Research Fund, PRIHS-6, and Mitacs Accelerate fund. DM-D-L is supported by CASA Mental Health as the CASA Research Chair. DAR is supported by the Alberta Health Services Chair in Mental Health Research.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Ethics Board of the University of Alberta gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Leveraging neuroscience education to address stigma related to opioid use disorder (OUD) in the community: A pilot study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Leveraging neuroscience education to address stigma related to opioid use disorder (OUD) in the community: A pilot study
Evan J. Kyzar, Melissa Arbuckle, Adam Abba-Aji, Krishna Balachandra, Joseph Cooper, Adriane Dela Cruz, Ellen Edens, Brady Heward, Michael Jibson, Ayana Jordan, Daniel Moreno-De-Luca, Hannah Pazderka, Mohit Singh, Jeremy Weleff, Bernice Yau, Justin Young, David A. Ross
medRxiv 2023.12.11.23299824; doi: https://doi.org/10.1101/2023.12.11.23299824
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Leveraging neuroscience education to address stigma related to opioid use disorder (OUD) in the community: A pilot study
Evan J. Kyzar, Melissa Arbuckle, Adam Abba-Aji, Krishna Balachandra, Joseph Cooper, Adriane Dela Cruz, Ellen Edens, Brady Heward, Michael Jibson, Ayana Jordan, Daniel Moreno-De-Luca, Hannah Pazderka, Mohit Singh, Jeremy Weleff, Bernice Yau, Justin Young, David A. Ross
medRxiv 2023.12.11.23299824; doi: https://doi.org/10.1101/2023.12.11.23299824

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)